Patent · US Active

Amorphous lercanidipine hydrochloride and uses thereof

US7820701B2 · kind B2 · utility

0Cited by

6References

22Claims

0Family size

Assignee

Recordati Ireland Ltd. · IE

Inventors

Amedeo Leonardi · Milano, IT
Gianni Motta · Barlassina, IT
Fabio Berlati · Milano, IT

Key dates

Filing date	Feb 27, 2006
Grant date	Oct 26, 2010
Priority date	—
Expiry date	Jul 21, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a substantially pure amorphous lercanidipine hydrochloride having a purity of at least 95% pure, preferably at least about 97% pure, more preferably at least about 99% pure, and still more preferably at least about 99.5% pure. The invention further relates to methods of preparing substantially pure amorphous lercanidipine, as well as methods of providing rapid relief from hypertension by administering the substantially pure amorphous lercanidipine hydrochloride of the present invention to a patient in need of such treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.